PVLA
As of 2026-11-06, Palvella Therapeutics, Inc. (PVLA) has a market capitalization of $2.25 B, making it the #1998 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $2.25 B |
| 2026-11-05 | $2.25 B |
| 2026-11-04 | $2.33 B |
| 2026-11-03 | $2.18 B |
| 2026-11-02 | $2.10 B |
| 2026-11-01 | $2.10 B |
| 2026-10-31 | $2.10 B |
| 2026-10-30 | $2.12 B |
| 2026-10-29 | $2.17 B |
| 2026-10-28 | $2.12 B |
| 2026-10-27 | $1.88 B |
| 2026-10-26 | $1.81 B |
As of 2026-11-06, Palvella Therapeutics, Inc. (PVLA) has a market capitalization of $2.25 B, making it the #1998 most valuable US-listed company.
Palvella Therapeutics, Inc. is the #1998 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $1.79 B |
| 2026-10-24 | $1.79 B |
| 2026-10-23 | $1.79 B |
| 2026-10-22 | $1.80 B |
| 2026-10-21 | $1.82 B |
| 2026-10-20 | $1.78 B |
| 2026-10-19 | $1.76 B |
| 2026-10-18 | $1.73 B |
| 2026-10-17 | $1.73 B |
| 2026-10-16 | $1.83 B |
| 2026-10-15 | $1.80 B |
| 2026-10-14 | $1.76 B |
| 2026-10-13 | $1.84 B |
| 2026-10-12 | $1.93 B |
| 2026-10-11 | $1.99 B |
| 2026-10-10 | $1.99 B |
| 2026-10-09 | $1.98 B |
| 2026-10-08 | $1.88 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.